ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987

DeVita Asks Panel For Help On Filling Vacancies, Object To “Effort To Get Us Back To 1970 Level”

November 21, 1980

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

Pain Relievers Protect Against Breast Cancer

April 25, 2003